Advances in the clinical management of uveal melanoma.
Carvajal RD, Sacco JJ, Jager MJ, Eschelman DJ, Olofsson Bagge R, Harbour JW, Chieng ND, Patel SP, Joshua AM, Piperno-Neumann S.
Nat Rev Clin Oncol. 2023 Feb;20(2):99-115. doi: 10.1038/s41571-022-00714-1. Epub 2023 Jan 4.
Metastatic uveal melanoma: The final frontier.
Rantala ES, Hernberg MM, Piperno-Neumann S, Grossniklaus HE, Kivelä TT.
Prog Retin Eye Res. 2022 Sep;90:101041. doi: 10.1016/j.preteyeres.2022.101041. Epub 2022 Jan 6.
Uveal melanoma: In the era of new treatments.
Wespiser M, Neidhardt E, Negrier S.
Cancer Treat Rev. 2023 Sep;119:102599. doi: 10.1016/j.ctrv.2023.102599. Epub 2023 Jul 7.
Proteomics in uveal melanoma.
Heiferman MJ, Mahajan VB, Mruthyunjaya P.
Curr Opin Ophthalmol. 2022 May 1;33(3):202-210. doi: 10.1097/ICU.0000000000000835. Epub 2022 Jan 31.
Uveal Melanoma Biopsy. A Review.
Rusňák Š, Hecová L, Kasl Z, Sobotová M, Hauer L.
Cesk Slov Oftalmol. 2020 Winter;76(6):247-252. doi: 10.31348/2020/9.
Uveal melanoma pathobiology: Metastasis to the liver.
Bustamante P, Piquet L, Landreville S, Burnier JV.
Semin Cancer Biol. 2021 Jun;71:65-85. doi: 10.1016/j.semcancer.2020.05.003. Epub 2020 May 22.
Tebentafusp for the treatment of HLA-A*02:01-positive adult patients with unresectable or metastatic uveal melanoma.
Chen LN, Carvajal RD.
Expert Rev Anticancer Ther. 2022 Oct;22(10):1017-1027. doi: 10.1080/14737140.2022.2124971. Epub 2022 Sep 19.
Therapy of uveal melanoma A Review.
Rusňák Š, Hecová L, Kasl Z, Sobotová M, Hauer L.
Cesk Slov Oftalmol. 2020 Fall;77(1):1-13. doi: 10.31348/2020/10.
Radiotherapy in Uveal Melanoma: A Review of Ocular Complications.
Banou L, Tsani Z, Arvanitogiannis K, Pavlaki M, Dastiridou A, Androudi S.
Curr Oncol. 2023 Jul 3;30(7):6374-6396. doi: 10.3390/curroncol30070470.
Uveal Melanoma Treatment and Prognostication.
Dogrusöz M, Jager MJ, Damato B.
Asia Pac J Ophthalmol (Phila). 2017 Mar-Apr;6(2):186-196. doi: 10.22608/APO.201734.
